ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

TENX Tenax Therapeutics Inc

3.80
0.01 (0.26%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Tenax Therapeutics Inc TENX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 0.26% 3.80 08:26:00
始値 安値 高値 終値 前日終値
3.83 3.78 3.86 3.84 3.79
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3020:30GLOBETenax Therapeutics Announces New U.S. Patent Covering the..
2024/4/0921:30GLOBETenax Therapeutics to Host KOL Event: “LEVEL Setting: the..
2024/3/2821:30GLOBETenax Therapeutics Provides Business and Clinical..
2024/3/1221:30GLOBETenax Therapeutics to Present at the 36th Annual Roth..
2024/2/2923:00GLOBETenax Therapeutics Announces Oral Presentation of..
2024/2/2706:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/2406:30EDGAR2Form 8-K - Current report
2024/2/2106:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/2022:33EDGAR2Form 8-K - Current report
2024/2/2022:30GLOBETenax Therapeutics Announces Global License Amendment that..
2024/2/1701:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1609:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1306:46EDGAR2Form 8-K - Current report
2024/2/0822:16GLOBETenax Therapeutics Announces Pricing of Approximately $9..
2024/2/0814:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/0810:01GLOBETenax Therapeutics Enrolls First Patient in Phase 3 LEVEL..
2024/2/0622:56EDGAR2Form 8-K - Current report
2024/2/0622:30GLOBETenax Therapeutics Announces USPTO Grants Notice of..
2024/2/0307:24EDGAR2Form S-1/A - General form for registration of securities..
2024/2/0206:20EDGAR2Form S-1/A - General form for registration of securities..
2024/1/2006:30EDGAR2Form 8-K - Current report
2024/1/1307:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/1306:30EDGAR2Form 8-K - Current report
2024/1/0606:46EDGAR2Form 8-K - Current report
2023/12/0206:47EDGAR2Form S-1 - General form for registration of securities under..
2023/12/0206:01EDGAR2Form 8-K - Current report
2023/11/1722:30GLOBETenax Therapeutics Announces Professor Javed Butler, M.D.,..
2023/11/1506:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/1406:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1323:10EDGAR2Form 8-K - Current report
2023/11/1322:30GLOBETenax Therapeutics Announces FDA Clearance of IND for..
2023/9/3005:11EDGAR2Form 8-K - Current report
2023/8/1605:05EDGAR2Form 8-K - Current report
2023/8/1505:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/2005:30EDGAR2Form 8-K - Current report
2023/7/1921:30GLOBETenax Therapeutics Issued U.S. Patent for Oral Levosimendan..

最近閲覧した銘柄

Delayed Upgrade Clock